Menu
Fechar
hrs4r
 I want to donate
Firma
JORDI GICH-FULLÀ
Position
Investigador/a Consolidat - R3
Established Researchers - R3
Projectes
Publicacions

Projectes

Neurodegeneration and Neuroinflammation

Estudio de biomarcadores moleculares de resiliencia cognitiva en el envejecimiento cerebral y en la neurodegeneración

Codi oficial: Estudio de biomarcadores moleculares neurodegeneración Start date:01/01/2022 Data fi: 30/06/2025 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ Organisme finançador: FRANCISCO SORIA MELGUIZO, S.A
Neurodegeneration and Neuroinflammation

PROCOGBIO Predicción de la progresión del deterioro cognitivo en la esclerosis múltiple combinando biomarcadores circulantes en sangre

Codi oficial: PI23/00517 Start date:01/01/2024 Data fi: 31/12/2026 Investigador/a principal: ANNA QUIROGA VARELA, LLUÍS RAMIÓ TORRENTÀ Organisme finançador: INSTITUTO DE SALUD CARLOS III
Neurodegeneration and Neuroinflammation

A RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE MS-LINE! COGNITIVE REHABILITATION PROGRAM FOR PEOPLE WITH MS

Codi oficial: ECTRIMS2024: 344 Start date:23/09/2024 Data fi: 22/09/2025 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ, ÓSCAR DANIEL AYALA NARIÑO Organisme finançador: EUROPEAN COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS
Neurodegeneration and Neuroinflammation

EM-Line!Kids: rehabilitació cognitiva des de casa per a pacients en edat pediàtrica.

Codi oficial: 2024 PROD 00183 Start date:02/12/2024 Data fi: 01/06/2026 Investigador/a principal: JORDI GICH FULLÀ Organisme finançador: AGÈNCIA DE GESTIÓ UNIVERSITARIS I RECERCA
Neurodegeneration and Neuroinflammation

Red de Enfermedades Inflamatorias (REI)

Codi oficial: RD24/0007/0005 Start date:01/01/2025 Data fi: 31/12/2027 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ Organisme finançador: INSTITUTO DE SALUD CARLOS III

Publicacions

Gich J, Salavedra-Pont J, Coll-Martinez C, Quintana E, Álvarez-Bravo G, Robles-Cedeño R, Buxó M, Contreras-Rodriguez O, Ramió-Torrentà L

The nature of memory impairment in multiple sclerosis: understanding different patterns over the course of the disease

Frontiers in Psychology, 2024, 14, 1269794-1269794 dx.doi.org/10.3389/fpsyg.2023.1269794
Contreras-Rodriguez O, Blasco G, Biarnés C, Puig J, Arnoriaga-Rodríguez M, Coll-Martinez C, Gich J, Ramió-Torrentà L, Motger-Albertí A, Pérez-Brocal V, Moya A, Radua J, Manuel Fernández-Real J

Unraveling the gut-brain connection: The association of microbiota-linked structural brain biomarkers with behavior and mental health

PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024, 78, 339-346 dx.doi.org/10.1111/pcn.13655
Pons, JMH, Coll-Martínez, C, Benavides, AM, Gifreu, A, Pont, JS, Bravo, GCA, Fulla, JG, Torrenta, LRI, Quiroga-Varela, A

Interleukin-8 plasma levels as a potential biomarker for predicting middle-term cognitive outcomes

MULTIPLE SCLEROSIS JOURNAL, 2024, 30, 976-977
Coll-Martínez, C, Pont, JS, Pons, JMH, Benavides, AM, Gifreu, A, Bravo, GCA, Quiroga-Varela, A, Ramió-Torrentà, L, Fulla, JG

Cognitive outcomes through MS disease course: 10-year follow-up

MULTIPLE SCLEROSIS JOURNAL, 2024, 30, 747-748
Coll-Martínez, C, Pons, JMH, Benavides, AM, Bravo, GCA, Gifreu, A, Pont, JS, Fulla, JG, Torrenta, LRI, Quiroga-Varela, A

Prognostic potential of plasma Interleukin-6 levels as biomarker for long-term cognitive performance

MULTIPLE SCLEROSIS JOURNAL, 2024, 30, 981-981
Quiroga-Varela, A, Pons, JMH, Coll-Martínez, C, Benavides, AM, Pont, JS, Gifreu, A, Bravo, GCA, Fulla, JG, Ramió-Torrentà, L

Exploring neurogranin as a potential biomarker for cognitive impairment and disease activity in multiple sclerosis

MULTIPLE SCLEROSIS JOURNAL, 2024, 30, 590-590
Coll-Martinez C, Salavedra-Pont J, Buxó M, Quintana E, Quiroga-Varela A, Robles-Cedeño R, Puig M, Álvarez-Bravo G, Ramió-Torrentà L, Gich J

Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors

Frontiers in Psychology, 2023, 14, 1163112-1163112 dx.doi.org/10.3389/fpsyg.2023.1163112
Domínguez, DL, Reinoso, CC, Fulla, JG, Nierga, IP

Brain sagging syndrome, a potentially reversible cause of subacute ataxia and dementia. A case report

Neurologia, 2023, 38, 221-223 dx.doi.org/10.1016/j.nrl.2022.04.002
Bravo, GCA, Benavides, AM, Quiroga-Varela, A, Casadevall, MP, Gifreu, A, Coll-Martínez, C, Fulla, JG, Ramio-Torrentà, L

Relationship between human leukocyte antigens (HLA) and "idiopathic" myelitis, encephalitis and optic neuritis

MULTIPLE SCLEROSIS JOURNAL, 2023, 29, 656-657
Coll-Martínez, C, Quiroga-Varela, A, Pont, JS, Pons, JMH, Benavides, AM, Guimerans, LMV, Casadevall, MP, Gifreu, A, Bravo, GCA, Fulla, JG, Ramió-Torrentà, L

Neurofilament light chain levels in CSF as a potential biomarker for predicting middle-term cognitive outcomes

MULTIPLE SCLEROSIS JOURNAL, 2023, 29, 903-904

Formulari de contacte

About IDIBGI!

 menu